Sotera Health (NASDAQ:SHC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Sotera Health (NASDAQ:SHC) has received a consensus rating of “Moderate Buy” from the five ratings firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $16.00.

Several research firms have recently issued reports on SHC. Barclays dropped their price target on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research note on Friday, February 28th. The Goldman Sachs Group initiated coverage on Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target on the stock.

Sotera Health Stock Down 2.3 %

NASDAQ:SHC opened at $11.93 on Wednesday. Sotera Health has a one year low of $10.71 and a one year high of $17.08. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The company has a market cap of $3.38 billion, a PE ratio of 47.72 and a beta of 1.92. The firm’s 50 day simple moving average is $12.90 and its 200 day simple moving average is $14.08.

Hedge Funds Weigh In On Sotera Health

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Blue Trust Inc. grew its holdings in Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after acquiring an additional 1,140 shares during the period. Quarry LP acquired a new stake in Sotera Health during the fourth quarter worth approximately $28,000. True Wealth Design LLC bought a new stake in Sotera Health in the third quarter worth approximately $32,000. GAMMA Investing LLC lifted its stake in Sotera Health by 37.5% in the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock valued at $56,000 after buying an additional 1,121 shares during the period. Finally, Tower Research Capital LLC TRC lifted its stake in Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock valued at $82,000 after buying an additional 1,640 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.